Latest Articles

Publication Date
Endometriosis influencers on Instagram: Who are they and what are they posting?

To examine endometriosis-related content on Instagram, a platform increasingly used for health communication, to understand: 1) the identity of Instagram content creators; 2) themes, tones, and emotions evoked from posts; …

Published: Feb. 6, 2025, midnight
Comparison of vaginal versus intramuscular progesterone in programmed cycles for frozen-thawed blastocyst transfer in patients with endometriosis.

Previous studies have shown that due to the presence of endometrium progesterone resistance in patients with endometriosis, it is considered that higher levels of progesterone may be required to achieve …

Published: Feb. 6, 2025, midnight
Real world perspectives on endometriosis disease phenotyping through surgery, omics, health data, and artificial intelligence.

Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgical …

Published: Feb. 6, 2025, midnight
The impact of MTHFR and VDR polymorphisms on endometriosis susceptibility: Insights from a systematic review and meta-analysis.

The VDR and MTHFR polymorphisms have been linked to many gynecological and obstetrical diseases. However, there is still a pressing need for a systematic review and meta-analysis to synthesize the …

Published: Feb. 6, 2025, midnight
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today

ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today

Published: Feb. 5, 2025, 7:31 p.m.
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today

Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Endometriosis Linked to Trauma, Stress: New Evidence - Mirage News

Endometriosis Linked to Trauma, Stress: New Evidence Mirage News

Published: Feb. 5, 2025, 4:34 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Imaging Technology News

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Imaging Technology News

Published: Feb. 5, 2025, 3:56 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - StreetInsider.com

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent StreetInsider.com

Published: Feb. 5, 2025, 1:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!